BioBrace® in Arthroscopic Brostrom Lateral Ankle Ligament Repair

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHancock Orthopedics

About this trial

The purpose of this investigation is to evaluate pre- and post-operative patient reported outcomes and functional scores after an all-arthroscopic Brostrom repair using either a suture anchor construct alone or suture anchors with the BioBrace Implant.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

At least 18 years of age at the time of surgery.

Able to read, understand and sign the informed consent form.

Willing to be available to attend each protocol required visit and complete the study required questionnaires.

Scheduled to undergo primary, arthroscopic Brostrom repair.

Disqualifiers

Previous Brostrom surgery.

Concomitant procedures that would change the post operative course/recovery (i.e. total ankle replacement, OCD repair, foot/ankle osteotomies) as determined by the Investigator.

Currently participating or plans to enroll in another clinical trial during this study that would affect the outcomes of this study as determined by the Investigator.

History of non-compliance with medical treatment or clinical trial participation.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Brostrom repair with augmentation

    Device

    Brostrom repair with BioBrace

  • Brostrom repair without augmentation

    Other intervention

    Brostrom repair without BioBrace

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Control - Repair Only GroupSham comparator 1 intervention
Group B: BioBrace Augment GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

American Orthopedic Foot and Ankle Society score (AOFAS)

The AOFAS Score is a clinician-based assessment tool that evaluates pain, function, and alignment in patients with foot and ankle disorders. It provides a composite score ranging from 0 to 100, with higher scores indicating better function. The system includes region-specific scales (e.g., ankle-hindfoot, midfoot, hallux) and combines both patient-reported symptoms and objective clinician findings

Time frame
Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months
2

Foot Function Index (FFI)

The Foot Function Index (FFI) is a patient-reported questionnaire used to assess how foot conditions affect pain, disability, and activity limitation. It includes 23 items rated on a 0-10 scale, with higher scores indicating greater impairment in foot function.

Time frame
Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months
3

Visual Analog Scale (VAS)

The Visual Analog Scale (VAS) is a tool used to measure the intensity of pain or other subjective symptoms. It consists of a 10-cm line labeled "no pain" at one end and "worst imaginable pain" at the other; patients mark their pain level on the line, which is then measured to provide a numerical score from 0 to 100.

Time frame
Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months
4

Karlsson-Peterson score

The Karlsson-Peterson Score is a functional ankle assessment tool that evaluates symptoms such as pain, swelling, instability, stiffness, stair-climbing ability, running ability, work/activity level, and need for support, producing a total score up to 100, with higher scores indicating better ankle function.

Time frame
Baseline, 1, 3, and 6 weeks & 3, 6, and 12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hancock Orthopedics

Lead sponsor

CONMED Corporation

Collaborator